Stage I high-grade non-Hodgkin's lymphoma

Acta Oncologica

Volumn 39, Issue 7, 2000, Pages 865-872

  Lote, K ^a   Holte, H ^a   Nome, O ^a   Langholm, R ^a   Kvaloy S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033675270     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750063631     Document Type: Conference Paper

References (28)

1. A predictive model for aggressive Non-Hodgkin's lymphoma
2. The national cancer data base report on non-Hodgkin's lymphoma
3. High-grade non-Hodgkin's lymphoma stage I. A retrospective study of treatment, outcome and prognostic factors in 213 patients
4. Clinical stage I non-Hodgkin's lymphoma: Longterm follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
5. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types
6. Initial chemotherapy for clinically localized lymphomas of unfavorable histology
7. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma
8. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy
9. Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy
10. Treatment for non-Hodgkin's lymphoma (stage I-II) of the elderly: Usefulness of local and regional irradiation and reduced dose chemotherapy
11. Non-Hodgkin's lymphoma
12. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma
13. Chemoradiotherapy for localized non-Hodgkin's lymphoma
14. Prognostic factors in non-Hodgkin's lymphoma stage I treated with radiotherapy
15. Report of the committee on Hodgkin's disease staging classification
16. Hydroxyl-daunomycin (adriamycin) combination chemotherapy in malignant lymphoma
17. High-grade non-Hodgkin's lymphoma treated in northern Norway - Treatment, outcome, and prognostic factors
18. CHOP may have been part of the beginning but certainly not the end: Issues in risk-related therapy of large cell lymphoma
19. Combined modality treatment for stage I non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy
20. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
21. Non-Hodgkin's lymphoma of the testis
22. The management and outcome of stage IAE non-Hodgkin's lymphoma of the testis
23. Clinical features of testicular non-Hodgkin's lymphoma
24. Testicular lymphoma is associated with a high incidence of extranodal recurrence
25. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: Analysis of 117 cases from a single institution
26. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma